Close

BofA Securities Downgrades Talis Biomedical Corp. (TLIS) to Underperform

January 7, 2022 7:41 AM EST Send to a Friend
BofA Securities analyst Derik de Bruin downgraded Talis Biomedical Corp. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login